Running a genetic screening may help to diagnose familial amyloid polyneuropathy (FAP) among people with sensory-motor polyneuropathy — damage…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
New 15-year data from a global study involving more than 6,000 people with ATTR amyloidosis, an umbrella term for conditions…
A little more than a year of treatment with eplontersen was found to stabilize or even improve the heart’s…
Blood levels of neurofilament light chain (NfL) — a marker of nerve cell damage — can separate people with symptoms…
A rare mutation in the TTR gene was identified as the cause of familial amyloid polyneuropathy (FAP) in a…
Machine learning, a form of artificial intelligence, may help doctors to identify people suspected of familial amyloid polyneuropathy (FAP)…
Tegsedi (inotersen) helped to stabilize familial amyloid polyneuropathy (FAP) symptoms in a 71-year-old man, but its use also was associated…
An elderly man in Germany was found to carry one copy of a new mutation in the TTR gene that…
A diagnosis of familial amyloid polyneuropathy (FAP) due to a mutation in the TTR gene was made in an…
A man with familial amyloid polyneuropathy (FAP) developed eye problems years after he was found to have an uncommon…